Oncolytics Biotech's Progress on the GOBLET Study and Expansion in the U.S. Market Oncolytics Biotech updates on the GOBLET clinical trial, key findings, and U.S. expansion plans, highlighting promising results in gastrointestinal cancer treatment.

Oncolytics Biotech's Progress on the GOBLET Study and Expansion in the U.S. Market #USA #San_Diego #Oncolytics_Biotech #pelareorep #GOBLET_Study

Oncolytics Biotech's Regulatory Approval Fuels New Hope for Pancreatic Cancer Treatment Advancement Oncolytics Biotech has received essential regulatory approval to continue its trial for a pancreatic cancer treatment. This milestone may lead to improved patient outcomes.

Oncolytics Biotech's Regulatory Approval Fuels New Hope for Pancreatic Cancer Treatment Advancement #United_States #San_Diego #Oncolytics_Biotech #pelareorep #GOBLET_Study